Stocks analysis

Analysis for BX

$109.20 +2.99 (+2.82%)
  • 📈 Growth — 26/30
  • 💰 Profitability — 18/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 15/20
  • ⚠️ Risk — 8/10
Overall Score: 79/100

Summary:


📈 Growth & Financial Trajectory

Eight quarters show a steady revenue enhancement from about $2.80B in 2024 Q1 to $5.04B in 2026 Q2, a growth of roughly 80%, with occasional dips (notably 2025 Q3 after 2025 Q4). Net income rose from about $1.63B to $2.36B, signaling stronger profitability despite volatility.

💰 Margins & Cash Flow

Operating margin sits in the 40-50% range, with 2026 Q2 peaking above that. Net income margin tracks this strength. Cash flow from operating activities remained robust, e.g., $1.94B in 2026 Q2, while investing cash flow was cash outflow and financing cash flow negative, yielding a modest net cash improvement.

🛡️ Balance Sheet & Liquidity

Total assets near $50B; long-term debt around $13.3B; equity around $21.1B; current liabilities generally aligned with current assets, supporting liquidity. The balance sheet shows durable capital structure with temporary redeemable equity.

⚠️ Key Drivers & Risks

  • Drivers: Strong fee-based earnings from alternative asset management; diversified asset classes and growth in performance fees.
  • Risks: Market cyclicality and reliance on performance fees; valuation sensitivity and potential fee compression.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $153.30B
P/E Ratio 43.56
Forward P/E 18.75
P/S Ratio 9.52
P/B Ratio 15.50
EV / EBITDA 21.53
Profitability & Returns
Gross Margin 83.07%
Operating Margin 47.20%
Net Margin 21.84%
ROE 40.87%
ROIC 16.49%
Financial Health & Liquidity
Current Ratio 0.68
Quick Ratio 0.68
Financial Scale & Cash Flow
Revenue $16.11B
Net Income $3.52B
FCF Yield 3.58%
Free Cash Flow $5.49B
Total Debt To Equity 1.46